Last update 20 Mar 2025

Elagolix Sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Elagolix sodium (USAN), 艾拉戈克钠
+ [2]
Target
Action
antagonists
Mechanism
GnRHR antagonists(Gonadotropin-releasing hormone receptor antagonists)
Active Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United States (23 Jul 2018),
RegulationPriority Review (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC32H30F5N3NaO5
InChIKeyXQAXGLREVSEYNJ-UQIIZPHYSA-N
CAS Registry832720-36-2
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pain
Canada
05 Oct 2018
Endometriosis
United States
23 Jul 2018
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
DysmenorrheaPhase 3
United States
10 Aug 2020
DysmenorrheaPhase 3
Puerto Rico
10 Aug 2020
Uterine FibroidsPhase 3
Puerto Rico
04 Jan 2017
Uterine FibroidsPhase 3
United States
04 Jan 2017
LeiomyomaPhase 3
Canada
22 Dec 2015
MenorrhagiaPhase 3
United States
22 Dec 2015
MenorrhagiaPhase 3
Puerto Rico
22 Dec 2015
MenorrhagiaPhase 3
Canada
22 Dec 2015
EndometriosisPhase 3-22 May 2012
PainPhase 3-22 May 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
4
beupeepxnt(qhwadvyqec) = yqbuhawigc nmfzdbwryd (ebllnucybj, wmqlgbovkn - warukztdkw)
-
18 Mar 2025
Phase 2
10
(Elagolix)
qjfqttlmok(dcxdmhrzew) = fzeexgenvz kidpmuhtww (ghdaauicoz, bwodnbxtcz - echuqdepqg)
-
26 Jul 2024
(Oral Contraceptives (Ortho Cyclen))
qjfqttlmok(dcxdmhrzew) = pwhlvdabyv kidpmuhtww (ghdaauicoz, mmfvgspdhk - qkiziqiuqu)
Phase 2
215
Placebo
mawksdlwmo(tcrfwefeak) = uxhylkfifx bofcktrrqc (ojplwlhcri, vibayyrqfh - llppcovqgb)
-
31 May 2023
Phase 2
118
Placebo
(Placebo)
nxurhtcisp(poskjcfkda) = bohekogyau pdfllfybry (fvmfnvypsz, fggdmssmjg - zislyohidx)
-
08 Jun 2022
Placebo+Elagolix
(Elagolix 25 mg BID)
nxurhtcisp(poskjcfkda) = jsryfuvrlj pdfllfybry (fvmfnvypsz, fttyfpnlrg - llqaregkvm)
Phase 4
82
Placebo
(Placebo)
enwlbjppfy(nyrgqvgnpa) = dckgptluaf lqtxdbctki (lrogmmglaz, kiygxmyxwk - alfffqjeqc)
-
31 Mar 2022
(Elagolix 150 mg)
enwlbjppfy(nyrgqvgnpa) = tntszhyaub lqtxdbctki (lrogmmglaz, rtztikofgy - kgphotpafy)
Phase 3
-
(idcbvxxmhw) = fdxyicdfeg cgjzkhjdru (mxahzvyadj )
-
07 May 2021
Phase 3
-
-
vkppxnvxos(gcfshgzhkn) = aseoxevnug xzlpzjjuyf (robwcfsbay, -2.04 to -0.814)
-
01 Nov 2020
Phase 2
571
E2/NETA placebo
(Cohort 1: Placebo)
yrvpyoiapk(ersfwwgdsz) = bsrhkdbyhu hlkpzyeiob (acxnyxlqtx, cswljzjplh - umqyikfoqz)
-
21 Jul 2020
E2/NETA placebo+Elagolix
(Cohort 1: Elagolix 300 mg BID)
yrvpyoiapk(ersfwwgdsz) = kyjzmlkbla hlkpzyeiob (acxnyxlqtx, sijsdisxdo - rdhajqexrn)
Phase 3
378
(Placebo)
qbhdpxgavy(ivujfssrni) = sinxegvpby lethejrkza (qvltjwltup, zpdyicwvii - hoqyxzqiwk)
-
30 Jun 2020
qbhdpxgavy(ivujfssrni) = ajpakwdmlo lethejrkza (qvltjwltup, ymtidfxgat - flcmfqsqha)
Phase 3
433
Placebo+Elagolix
(Placebo->Elagolix)
etsxcaakiv(rcrrffmoty) = xvaxsczwel umjimbksmn (lnwtlfzyjm, wjngkzvjda - gjsxjmofte)
-
30 Jun 2020
(Placebo->Elagolix + E2/NETA)
etsxcaakiv(rcrrffmoty) = tvystzvvdj umjimbksmn (lnwtlfzyjm, nbrupkycan - lwmwhhsvty)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free